Advertisement

Topics

Biogen Idec Inc. Company Profile

13:26 EST 18th December 2017 | BioPortfolio

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients worldwide benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com.


News Articles [330 Associated News Articles listed on BioPortfolio]

Hepatic Safety Of Biogen Idec’s Zinbryta Under Close Scrutiny In EU

The EU review of Biogen Idec’s MS drug Zinbryta is continuing as a special group at the European Medicines Agency...    

Creating an urgency to change. Mikael Nilsson, Director of Marketing Excellence, Biogen Idec

Of the 20 to 60 thousand thoughts we have per day only about 2% are new. Most of our thoughts are old thoughts and that tells us something about the challenge to change. During the eyeforpharma confe...

Biogen Idec: Jahresprognosen erhöht!

Kommentar von Volker GelfarthLiebe Leser, Biogen ist nach einer beeindruckenden Wachstumsserie in eine Übergangsphase mit moderateren Zuwächsen getreten. Die weltweit führende Marktstellung im 20 M...

wikifolio whispers p.m. zu Fuchs Petrolub, Zumtobel, Biogen Idec ...

Aktuelle Kommentare aus dem wikifolio-Universum. Mit Links zu den jeweiligen Depots, damit man sieht, wie erfolgreich die Kommentatoren mit ihren Einschätzungen sind und wie sich die genannten Inpu.....

Biogen, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 30092017] Prices from USD $175

Biogen, Inc. Strategy, SWOT and Corporate Finance ReportSummaryBiogen, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers ...

Biogen Appoints Anabella Villalobos Senior Vice President, Biotherapeutic & ...

BiogenMatt Fearer, +1-781-464-3260public.affairs@biogen.comorBenjamin Strain, +1-781-464-2442IR@biogen.com Read more...

EC approval for trastuzumab biosimilar Ontruzant

South Korean electronics giant Samsung and biotechnology company Biogen Idec’s joint venture Samsung Bioepis announced on 20 November 2017 that it had received European Commission (EC) approval for ...

Head to Head Survey: Biogen (BIIB) and Its Peers

Biogen is one of 45 public companies in the "Biopharmaceuticals" industry, but how does it contrast to its peers? We will compare Biogen to similar companies based on the strength of its analyst recom...

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Avonex [Biogen Idec MA Inc.]

AVONEX (Interferon beta-1a)IM Injection

Avonex [Biogen Idec MA Inc.]

AVONEX (Interferon beta-1a)IM Injection

Indium in 111 chloride [Mallinckrodt Inc.]

Indiclorhigh purity indium chloride in-111 sterile solution [Amersham Health]

INDICLORHigh Purity Indium Chloride In-111 Sterile Solution

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Comparative Evaluation of αCD40 (2C10R4) and αCD154 (5C8H1 and IDEC-131) in a Nonhuman Primate Cardiac Allotransplant Model.

Specific blockade of T cell costimulation pathway is a promising immunomodulatory approach being developed to replace our current clinical immunosuppression therapies. The goal of this study is to com...

Leveraging a CHO cell line toolkit to accelerate biotherapeutics into the clinic.

The Biogen upstream platform is capable of delivering equivalent quality material throughout the cell line generation process. This allows us to rapidly deliver high quality biopharmaceuticals to pati...

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma

This is a Phase I/II open-label, dose-escalating study in patients with metastatic colorectal cancer. The objectives of the study are to obtain information on the safety of radiolabeled I...

Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma

The purpose of this study is to determine whether anti-CD80 monoclonal antibody (IDEC-114) is effective in the treatment of follicular B-cell non-Hodgkin's lymphoma. This drug has never b...

Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma

To determine what side effects and what clinical effect, if any, the administration of this investigational product, IDEC-114 in combination with Rituxan® [Rituxan® as a single agent is ...

ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.

The purpose of this study is to see if we can find a new way to test how certain Multiple Sclerosis (MS) medications work in the body and to better understand how the medicines change cert...

Pregnancy Exposure Registry for AVONEX

This is an observational, exposure-registration and follow-up study, which will be conducted in the United States (US). The AVONEX® Pregnancy Exposure Registry is designed to monitor pre...

Companies [34 Associated Companies listed on BioPortfolio]

Biogen Idec Inc.

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufa...

Biogen Idec and Elan Corporation, plc

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufa...

Biogen Idec and Abbott

Biogen Idec uses cutting-edge science to discover, develop, manufacture and market therapies for serious diseases with a focus on neurology, immunology and hemophilia. Founded in ...

Biogen Idec and Portola Pharmaceuticals

Biogen Idec uses cutting-edge science to discover, develop, manufacture and market therapies for serious diseases with a focus on neurology, immunology and hemophilia. Founded in ...

Biogen Idec

Scientific excellence that achieves new standards of care drives the company's work. 17 products are currently in clinical development addressing a variety of key medical needs.With patients in more t...

More Information about "Biogen Idec Inc." on BioPortfolio

We have published hundreds of Biogen Idec Inc. news stories on BioPortfolio along with dozens of Biogen Idec Inc. Clinical Trials and PubMed Articles about Biogen Idec Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biogen Idec Inc. Companies in our database. You can also find out about relevant Biogen Idec Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record